AI Verdict
AMZN has stronger fundamentals based on our AI analysis.
MDCXW vs AMZN Fundamental Comparison
| Metric | MDCXW | AMZN |
|---|---|---|
| Revenue | $-197,382.0 | $716.9B |
| Net Income | $-47.3M | $77.7B |
| Net Margin | 23,954.3% | 10.8% |
| ROE | N/A | 18.9% |
| ROA | -469.9% | 9.5% |
| Current Ratio | 1.00x | 1.05x |
| Debt/Equity | N/A | 0.17x |
| EPS | $-2.74 | $7.17 |
Green = Better metric | Red = Weaker metric
You Might Also Compare
MDCXW vs AMZN: Frequently Asked Questions
Is MDCXW or AMZN a better buy in 2026?
Based on dual AI fundamental analysis (Claude and ChatGPT), AMZN has stronger fundamentals. MDCXW is rated STRONG SELL (95% confidence) while AMZN is rated BUY (81% confidence). This is not investment advice.
How does MDCXW compare to AMZN fundamentally?
Medicus Pharma Ltd. has ROE of N/A vs AMAZON COM INC's 18.9%. Net margins are 23,954.3% vs 10.8% respectively.
Which stock pays higher dividends, MDCXW or AMZN?
MDCXW has a dividend yield of N/A or no dividend while AMZN has N/A or no dividend. Check individual stock pages for detailed dividend history and payout ratios.
Should I invest in MDCXW or AMZN for long term?
For long-term investing, consider that MDCXW has STRONG SELL rating with 95% confidence, while AMZN has BUY rating with 81% confidence. Higher confidence indicates more consistent fundamentals from SEC filings. This is not investment advice - always do your own research.
What do the AI models say about MDCXW vs AMZN?
Our dual AI system (Claude by Anthropic and ChatGPT by OpenAI) analyzes SEC 10-K and 10-Q filings independently. For MDCXW vs AMZN, the AI consensus favors AMZN based on fundamental metrics including revenue growth, profitability, ROE, and balance sheet strength.